These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 10692777)

  • 41. The drug therapy of ulcerative colitis and of Crohn's disease.
    Tumen HJ
    Semin Drug Treat; 1974; 3(4):339-49. PubMed ID: 4150770
    [No Abstract]   [Full Text] [Related]  

  • 42. [Chronic inflammatory bowel diseases. Immunosuppressive drugs--good alternatives to steroids].
    MMW Fortschr Med; 2001 Jul; 143(26-27):54-6. PubMed ID: 11481920
    [No Abstract]   [Full Text] [Related]  

  • 43. How thiopurines are used for the treatment of inflammatory bowel diseases: an Italian survey.
    Saibeni S; Kohn A; Meucci G; Papi C;
    Dig Liver Dis; 2015 Feb; 47(2):170-3. PubMed ID: 25467827
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Recurrence-preventive (remission preserving) therapy of chronic inflammatory bowel diseases].
    Kruis W; Pohl C
    Dtsch Med Wochenschr; 1998 Jan; 123(4):85-7. PubMed ID: 9487288
    [No Abstract]   [Full Text] [Related]  

  • 45. Current status of drug therapy for inflammatory bowel disease.
    Peppercorn MA
    Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Azathioprine].
    Sasaki M; Fujiyama Y
    Nihon Rinsho; 2005 May; 63 Suppl 5():692-9. PubMed ID: 15954431
    [No Abstract]   [Full Text] [Related]  

  • 47. Immunosuppressive therapy for ulcerative colitis, ileitis, and granulomatous colitis.
    Wisch N; Korelitz BI
    Surg Clin North Am; 1972 Aug; 52(4):961-9. PubMed ID: 5047533
    [No Abstract]   [Full Text] [Related]  

  • 48. [Drug therapy of chronic inflammatory intestinal diseases].
    Raedler A; Reinecker C
    Immun Infekt; 1990 Aug; 18(4):121-6. PubMed ID: 2210794
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Conservative therapy of ulcerative colitis--long-term experience].
    Kölbel C; Goebell H
    Internist (Berl); 1991 Sep; 32(9):530-9. PubMed ID: 1683664
    [No Abstract]   [Full Text] [Related]  

  • 50. [Immunosuppression in inflammatory bowel disease: When, how and how long?].
    Gross V
    Dtsch Med Wochenschr; 2012 Sep; 137(37):1803-5. PubMed ID: 22956222
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Epstein-Barr virus-related lymphomas in patients with inflammatory bowel disease].
    Juffermans NP; Jager A; Kersten MJ; van Oers MH; Hommes DW
    Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1859-63. PubMed ID: 16128185
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Severe muscular weakness: an unusual adverse effect of azathioprine therapy.
    Karhadkar AS; Schwartz HJ; Arora M; Dutta SK
    J Clin Gastroenterol; 2006 Aug; 40(7):626-8. PubMed ID: 16917406
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 6-mercaptopurine in patients with inflammatory bowel disease and previous digestive intolerance of azathioprine.
    Domènech E; Nos P; Papo M; López-San Román A; Garcia-Planella E; Gassull MA
    Scand J Gastroenterol; 2005 Jan; 40(1):52-5. PubMed ID: 15841714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [6-Mercaptopurine and inflammatory bowel disease].
    de la Morena Madrigal EJ; Abreu García L
    Rev Esp Enferm Dig; 1996 Jun; 88(6):455-7. PubMed ID: 8755333
    [No Abstract]   [Full Text] [Related]  

  • 55. Re-introduction of azathioprine in previously intolerant patients.
    Green CJ; Mee AS
    Eur J Gastroenterol Hepatol; 2006 Jan; 18(1):17-9. PubMed ID: 16357614
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [News on Azathioprine in IBD].
    Teich N
    Z Gastroenterol; 2013 Oct; 51(10):1195-6. PubMed ID: 24122383
    [No Abstract]   [Full Text] [Related]  

  • 57. Management of medical problems in pregnancy--inflammatory bowel disease.
    Donaldson RM
    N Engl J Med; 1985 Jun; 312(25):1616-9. PubMed ID: 2860564
    [No Abstract]   [Full Text] [Related]  

  • 58. Letter: flu-like illness with mercaptopurine and azathioprine in inflammatory bowel disease.
    Heerasing N; Dowling D
    Aliment Pharmacol Ther; 2014 Jan; 39(1):116. PubMed ID: 24299329
    [No Abstract]   [Full Text] [Related]  

  • 59. [FAQs in chronic inflammatory bowel diseases. This way your patient stays in remission].
    Stiefelhagen P
    MMW Fortschr Med; 2011 Dec; 153(49-50):20-1. PubMed ID: 22308586
    [No Abstract]   [Full Text] [Related]  

  • 60. [6-mercaptopurine as a safe therapeutic alternative for patients with inflammatory bowel disease intolerant to azathioprine].
    Ott C
    Z Gastroenterol; 2014 Sep; 52(9):1093-4. PubMed ID: 25198089
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.